RegMed Daily, Closing Bell, 3/27/12, stocks are flapping around in narrow ranges as volume is again anemic, ATHX and TNTN earnings today as ASTM begins rising post $40M financing
End of Day, Cause and Effect Read more…
End of Day, Cause and Effect Read more…
The Vatican had planned to hold a conference on stem cell research next month – cancelled. Read more…
Based on the recent FDA inspection of OTC BB: SVFC, Read more…
ReNeuron notices of exercise of warrants originally issued in 3/09. Read more…
End of Day, Cause and Effect: Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
ASTM’s preclinical study demonstrates … the potential atheroprotective properties of ixmyelocel-T … Read more…
Good morning! Here’s what you … might need to know to start the day – short and to the point. Read more…
End of Day, Cause and Effect: Read more…

Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.